8247 — BioSino Bio-technology and Science Share Price
0.000.00%
Last trade - 00:00- HK$101.30m
- HK$219.40m
- CNY289.07m
- 15
- 67
- 14
- 18
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.44 | ||
| Price to Tang. Book | 0.51 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 0.32 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -9.72% | ||
| Return on Equity | -5.6% | ||
| Operating Margin | -8.15% | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | CNYm | 397.41 | 325.26 | 348.23 | 373.07 | 289.07 | n/a | n/a | -0.95% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
BIOSINO BIO-TECHNOLOGY AND SCIENCE INCORPORATION is a China-based company principally engaged in the research and development, manufacture, sales and distribution of in-vitro diagnostics reagent products. The Company’s products include mono diagnostic reagent products and double diagnostic reagent products. Its products categories include liver diseases category, kidney diseases category, lipid diseases category, cardiovascular diseases category, glycometabolism category, inorganic ion category, pancreas diseases category and specific protein category. Its products are sold to hospitals and medical institutions.
Directors
- Lebin Wu CHM (58)
- Peng Chen PRE (47)
- Yanglin Lin VCH (40)
- Zhe Sun NVC (44)
- Jianzhong Liu FID (46)
- Jiang Lin VPR (46)
- Xiaowan Zheng VPR (36)
- Yeung Cheung OTH (39)
- Woon Cheung Tung SEC (50)
- Yali Cheng NED (57)
- Qi Lu NID (40)
- Fujin Ren NID (53)
- Yongtang Zheng NID (57)
- Last Annual
- December 31st, 2023
- Last Interim
- December 31st, 2023
- Incorporated
- March 1st, 1988
- Public Since
- February 27th, 2006
- No. of Employees
- 537
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
- Stock Exchange of Hong Kong Limited
- Shares in Issue
- 144,707,176
- Address
- Changping Business Hotel Opposite,No.27,, BEIJING, 102200
- Web
- https://www.zhongsheng.com.cn/
- Phone
- +86 1080117700
- Auditors
- Ernst & Young
Upcoming Events for 8247
BioSino Bio-technology and Science Inc Annual Shareholders Meeting
Q2 2024 Biosino Bio-Technology and Science Inc Earnings Release
Similar to 8247
Acotec Scientific Holdings
Stock Exchange of Hong Kong Limited
Beijing Airdoc Technology Co
Stock Exchange of Hong Kong Limited
AK Medical Holdings
Stock Exchange of Hong Kong Limited
AMCO United Holding
Stock Exchange of Hong Kong Limited
Angelalign Technology
Stock Exchange of Hong Kong Limited
FAQ
What is the BioSino Bio-technology and Science share price?
As of Today at 19:04 UTC, shares in BioSino Bio-technology and Science are trading at HK$0.70. This share price information is delayed by 15 minutes.
How has the BioSino Bio-technology and Science share price performed this year?
Shares in BioSino Bio-technology and Science last closed at HK$0.70 and the price had moved by -41.67% over the past 365 days. In terms of relative price strength the BioSino Bio-technology and Science share price has underperformed the FTSE Developed Asia Pacific Index by -41.26% over the past year.
What are the analyst and broker recommendations for BioSino Bio-technology and Science?
There is no consensus recommendation for this security.
What is the BioSino Bio-technology and Science dividend yield?
BioSino Bio-technology and Science does not currently pay a dividend.
Does BioSino Bio-technology and Science pay a dividend?
BioSino Bio-technology and Science does not currently pay a dividend.
When does BioSino Bio-technology and Science next pay dividends?
BioSino Bio-technology and Science does not currently pay a dividend.
How do I buy BioSino Bio-technology and Science shares?
To buy shares in BioSino Bio-technology and Science you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of BioSino Bio-technology and Science?
As of the previous close price of HK$0.70, shares in BioSino Bio-technology and Science had a market capitalisation of HK$101.30m.
Where are BioSino Bio-technology and Science shares listed?
Here are the trading details for BioSino Bio-technology and Science:
- Country of listing: Hong Kong
- Exchange: HKG
- Ticker Symbol: 8247
What kind of share is BioSino Bio-technology and Science?
Based on an overall assessment of its quality, value and momentum BioSino Bio-technology and Science is currently classified as a Value Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a BioSino Bio-technology and Science share price forecast for 2024?
We could not find analyst target price data for this security.
What is the trend in the BioSino Bio-technology and Science share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like BioSino Bio-technology and Science. Over the past six months, its share price has underperformed the FTSE Developed Asia Pacific Index by -22.59%.
As of the last closing price of HK$0.70, shares in BioSino Bio-technology and Science were trading -11.68% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the BioSino Bio-technology and Science PE Ratio?
The BioSino Bio-technology and Science PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at HK$0.70.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of BioSino Bio-technology and Science?
BioSino Bio-technology and Science's management team is headed by:
- Lebin Wu - CHM
- Peng Chen - PRE
- Yanglin Lin - VCH
- Zhe Sun - NVC
- Jianzhong Liu - FID
- Jiang Lin - VPR
- Xiaowan Zheng - VPR
- Yeung Cheung - OTH
- Woon Cheung Tung - SEC
- Yali Cheng - NED
- Qi Lu - NID
- Fujin Ren - NID
- Yongtang Zheng - NID